Treatment of Relapsed/Refractory Myeloma (excluding T-cell redirection therapy)
Myeloid neoplasm post cytotoxic treatment (pCT-MN) in patients with myeloma- a UK single centre experience
Charalampia Kyriakou, MD, PhD
Consultant
University College London Hospitals NHS Foundation Trust
London, England, United Kingdom